Clinical Trials Browser

Standard of Care × Head & Neck × 90 days × Clear all

NCT02540174 2026-03-13

ALTAKRA-1405

Phase NA Completed

Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Tobacco Use

NCT05681039 2026-03-02

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT04890834 2026-02-19

Dyadic Yoga Intervention for the Improvement of Healthcare Utilization and Quality of Life in Patients With Head and Neck Cancer Undergoing Chemoradiation and Their Caregivers

Phase NA Active not recruiting

Head and Neck Carcinoma

NCT05031910 2026-02-17

Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality

Phase NA Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT06995508 2026-02-17

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT06532279 2026-02-02

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Stomatitis

NCT06912763 2026-01-26

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

Phase 2 Recruiting

Fibrosis, Head and Neck Neoplasms, Lymphedema